NAION (non-arteritic anterior ischemic optic neuropathy) is a rare condition caused by reduced blood flow to the front part of the optic nerve. It can cause visual field defects and sudden vision loss, which may be permanent.
Novo Nordisk maintains that no causal relationship between the drugs and the condition has been established and has not accepted any legal liability. Nevertheless, the Danish Patient Compensation Association has so far approved compensation in 31 cases, Bloomberg News reports.